The effect of Botox on chronic pelvic pain and sexual satisfaction in women with endometriosis

Phase 3

• Conditions: Endometriosis.; Endometriosis, unspecified; N80.9

• Registration Number: IRCT20091012002576N20
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 12 July 2021

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 32

Inclusion Criteria

Age 18-50 years
Chronic pelvic pain for at least 3 months
Do not start new analgesic strategies since one month before the intervention

Exclusion Criteria

The primary cause of chronic pelvic pain is the following: infection, gastrointestinal or psychological disorder, fibromyalgia, chronic fatigue syndrome
Severe untreated cervical dysplasia
History of hysterectomy and bilateral salpingo-oophorectomy
Allergy to botulinum toxin
Pregnancy or breastfeeding
History of urinary and fecal incontinence
Known pelvic prolapse
Neuromuscular disorders such as myasthenia gravis or Lambert Aton syndrome

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Chronic pelvic pain. Timepoint: Twice, before the intervention and one month after the intervention. Method of measurement: Visual Analog Scale (VAS Ruler).

Secondary Outcome Measures

Name	Time	Method
Sexual satisfaction rate. Timepoint: Once, at the end of the study. Method of measurement: Female Sexual Function Index Scoring.;Dysmenorrhea. Timepoint: Twice, before the intervention and one month after the intervention. Method of measurement: Visual Analog Scale (VAS Ruler).;Dyspareunia. Timepoint: Twice, before the intervention and one month after the intervention. Method of measurement: Visual Analog Scale (VAS Ruler).